补充和替代医学在一般实践中的作用在各国之间有何不同? 采访了曾在德国和欧洲其他地方工作过的医生
Klaus Linde1, Robert Bayer2, Jan Gehrmann2,3
1TUM School of Medicine and Health, Department Clinical Medicine, Technical University Munich, Institute for General Practice and Health Services Research, Munich, Germany. klaus.linde@mri.tum.de.
BMC complementary medicine and therapies
|September 3, 2024
概括
德国的全科医生使用补充和替代医学 (CAM) 比其他欧洲国家更多. 态度,患者期望和医疗保健系统的差异解释了CAM.
科学领域:
- 一般的做法一般的做法
- 补充和替代医学 (CAM)
- 欧洲医疗保健系统 欧洲医疗保健系统
背景情况:
- 德国的全科医生比许多其他国家更频繁地使用补充和替代医学 (CAM).
- 这项研究探讨了在德国和其他欧洲国家有经验的全科医生之间对CAM使用的感知差异.
研究的目的:
- 调查CAM在初级保健中的作用所感知的国家差异.
- 了解不同欧洲医疗保健系统的全科医生对CAM使用的影响因素.
主要方法:
- 采用半结构面试对12名全科医生进行的定性研究.
- 参与者有在德国和意大利,荷兰,挪威或英国的工作经验.
- 主题分析侧重于CAM,基于证据的医学 (EBM) 和处理不确定的情况.
主要成果:
- 一般医生一致认为,相比其他国家,CAM在德国的一般实践中更相关.
- 差异的主要原因包括:对CAM的证据基础的不同看法,沟通技巧培训,患者期望和国家特定的报销机制.
- 在荷兰,挪威和英国,更强的EBM/科学导向与较低的CAM使用有关.
结论:
- 在一般实践中,CAM的作用存在显著的跨国差异.
- 对CAM的态度,患者期望和医疗保健系统条件的根本差异是影响CAM整合的关键因素.
相关概念视频
Methods of Documentation VI: Case Management Model
564
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
564
Primary Healthcare Services
1.3K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.3K
Methods Of Healthcare Delivery System
3.2K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.2K
Ethical Issues
875
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Ethical Concerns in Healthcare:
875
Drug Control Governance: Regulatory Bodies and Their Impact
146
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
146
Bioequivalence: Overview
949
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
949


